Page last updated: 2024-10-22

amobarbital and Obesity

amobarbital has been researched along with Obesity in 8 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FEINBLATT, HM1
FEINBLATT, TM1
FERGUSON, EA1
NECHELES, H1
SORTER, H1
FAZEKAS, JF1
EHRMANTRAUT, WR1
KLEH, J1
GELVIN, EP1
KENIGSBERG, S1
BOYD, LJ1
TURNER, RW1
MILLIGAN, J1
ORT, F1
Hadler, AJ1
Bailly, PJ1
Harant, Y1
Lanfronchi, J1

Trials

1 trial available for amobarbital and Obesity

ArticleYear
Phenmetrazine vs. phenmetrazine with amobarbital for weight reduction: a double-blind study.
    Current therapeutic research, clinical and experimental, 1969, Volume: 11, Issue:12

    Topics: Adult; Aged; Amobarbital; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Obesity; Phen

1969

Other Studies

7 other studies available for amobarbital and Obesity

ArticleYear
Treatment of obesity with d-amphetamine hydrochloride and amobarbital.
    Medical times, 1956, Volume: 84, Issue:3

    Topics: Amobarbital; Amphetamine; Amphetamines; Barbiturates; Central Nervous System Stimulants; Dextroamphe

1956
Balanced amphetamine and sedative combination in the treatment of obesity.
    The Journal-lancet, 1957, Volume: 77, Issue:6

    Topics: Amobarbital; Amphetamine; Amphetamines; Barbiturates; Hypnotics and Sedatives; Obesity; Phenobarbita

1957
A study of the effectiveness of certain anorexigenic agents.
    The American journal of the medical sciences, 1958, Volume: 236, Issue:6

    Topics: Amobarbital; Amphetamine; Amphetamines; Obesity; Sympathomimetics

1958
Results of addition of liothyronine to a weight-reducing regimen.
    Journal of the American Medical Association, 1959, Jul-25, Volume: 170, Issue:13

    Topics: Amobarbital; Amphetamine; Amphetamines; Humans; Obesity; Triiodothyronine

1959
HYPERTENSION AND ITS COMPLICATIONS. 2.
    Nursing times, 1964, Jun-26, Volume: 60

    Topics: Amobarbital; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cold Temperature

1964
ADJUVANT TREATMENT OF OBESITY WITH AN ANORECTIC-CALORIGENIC AGENT.
    Clinical medicine (Northfield, Ill.), 1963, Volume: 70

    Topics: Adjuvants, Pharmaceutic; Amobarbital; Appetite Depressants; Energy Metabolism; Methamphetamine; Obes

1963
[Value of a neuroendocrine-acting drug in the treatment of female obesity].
    Le Progres medical, 1965, Sep-10, Volume: 93, Issue:14

    Topics: Adult; Amobarbital; Female; Humans; Hydroxypropiophenone; Middle Aged; Obesity

1965